AU3873697A - Novel aryl-pyridazines - Google Patents
Novel aryl-pyridazinesInfo
- Publication number
- AU3873697A AU3873697A AU38736/97A AU3873697A AU3873697A AU 3873697 A AU3873697 A AU 3873697A AU 38736/97 A AU38736/97 A AU 38736/97A AU 3873697 A AU3873697 A AU 3873697A AU 3873697 A AU3873697 A AU 3873697A
- Authority
- AU
- Australia
- Prior art keywords
- pyridazines
- novel aryl
- aryl
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/36—Benzo-cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9618487 | 1996-09-05 | ||
GBGB9618487.4A GB9618487D0 (en) | 1996-09-05 | 1996-09-05 | Pharmaceutically active compounds |
GBGB9619122.6A GB9619122D0 (en) | 1996-09-12 | 1996-09-12 | Pharmaceutically active compounds |
GB9619122 | 1996-09-12 | ||
GBGB9619642.3A GB9619642D0 (en) | 1996-09-20 | 1996-09-20 | Compounds |
GB9619642 | 1996-09-20 | ||
PCT/SE1997/001359 WO1998009969A1 (en) | 1996-09-05 | 1997-08-19 | Novel aryl-pyridazines |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3873697A true AU3873697A (en) | 1998-03-26 |
AU711539B2 AU711539B2 (en) | 1999-10-14 |
Family
ID=27268459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU38736/97A Ceased AU711539B2 (en) | 1996-09-05 | 1997-08-19 | Novel aryl-pyridazines |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP2001501180A (en) |
AR (1) | AR009322A1 (en) |
AU (1) | AU711539B2 (en) |
CA (1) | CA2263586A1 (en) |
ID (1) | ID17393A (en) |
WO (1) | WO1998009969A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE537151T1 (en) | 2006-10-31 | 2011-12-15 | Pfizer Prod Inc | PYRAZOLINE COMPOUNDS AS MINERALOCORTICOID RECEPTOR ANTAGONISTS |
US7999107B2 (en) | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
CN102372710A (en) * | 2010-08-18 | 2012-03-14 | 山东轩竹医药科技有限公司 | Fused cyclic compound being taken as mineral corticoid recept antagonist |
EP2937348B1 (en) * | 2012-12-22 | 2021-09-08 | Kbp Biosciences Pte. Ltd. | Process for the preparation of a compound used as mineralocorticoid receptor antagonist |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5045541A (en) * | 1987-11-02 | 1991-09-03 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused pyridazine compounds and their pharmaceutical use |
GB8818895D0 (en) * | 1988-08-09 | 1988-09-14 | Boots Co Plc | Therapeutic agents |
WO1991011448A1 (en) * | 1990-02-02 | 1991-08-08 | The Boots Company Plc | Therapeutic agents |
-
1997
- 1997-08-19 WO PCT/SE1997/001359 patent/WO1998009969A1/en not_active Application Discontinuation
- 1997-08-19 AU AU38736/97A patent/AU711539B2/en not_active Ceased
- 1997-08-19 CA CA002263586A patent/CA2263586A1/en not_active Abandoned
- 1997-08-19 JP JP10512539A patent/JP2001501180A/en active Pending
- 1997-08-25 AR ARP970103852A patent/AR009322A1/en unknown
- 1997-09-04 ID IDP973081A patent/ID17393A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR009322A1 (en) | 2000-04-12 |
ID17393A (en) | 1997-12-24 |
JP2001501180A (en) | 2001-01-30 |
CA2263586A1 (en) | 1998-03-12 |
AU711539B2 (en) | 1999-10-14 |
WO1998009969A1 (en) | 1998-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4040197A (en) | Microturbomachinery | |
AU3387997A (en) | Autonotification | |
AU2845197A (en) | Cycloalkano-pyridines | |
AU1251797A (en) | Novel heteroaryl-oxazolidinones | |
AU4945197A (en) | Aminothiophenecarboxamides | |
AU4013397A (en) | Arylalkanoylpyridazines | |
AU4176997A (en) | 3-alkyl-3-phenyl-piperidines | |
AU2684197A (en) | Handleset | |
AU5754898A (en) | Ussd-positioning | |
AU4218597A (en) | Superseat | |
AU5556998A (en) | 3-amino-1-cyanophenyl-uracils | |
AU2090897A (en) | Hydroxyhexahydropyridazines | |
AU3130597A (en) | Tristetraprolin | |
AU5221598A (en) | Sweet-toy | |
AU686068B2 (en) | Cremators | |
AU4332497A (en) | Endo-beta-galactosidase | |
AU2237197A (en) | Fishing-lure | |
AU5983798A (en) | Heterocyclyluracils | |
AU3873697A (en) | Novel aryl-pyridazines | |
AU4326397A (en) | Novel arylsulfotransferase | |
AU5002897A (en) | Gripper-accumulator | |
AU1597197A (en) | Thienoquinolines | |
AU5754598A (en) | Heterocyclyluracils | |
AU3557397A (en) | Double-tau-profile | |
AU7623898A (en) | Tri-pocket |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |